Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily J Gallagher

Showing results (1-10 of 76) with videos related to

Pageof 8
Sort By:
Diabetes Care|July 25, 2013
Epidemiology and molecular mechanisms tying obesity, diabetes, and the metabolic syndrome with cancerEmily J Gallagher, Derek LeRoith
Cancer Metastasis Reviews|July 8, 2022
Obesity and cancerEmily J Gallagher, Derek LeRoith
Nature Reviews. Cancer|September 10, 2020
Hyperinsulinaemia in cancerEmily J Gallagher, Derek LeRoith
Current Opinion in Endocrinology, Diabetes, and Obesity|August 27, 2013
Diabetes, antihyperglycemic medications and cancer risk: smoke or fire?Emily J Gallagher, Derek LeRoith
Endocrinology|May 5, 2011
Minireview: IGF, Insulin, and CancerEmily J Gallagher, Derek LeRoith
Cell Metabolism|June 11, 2013
Does a single nucleotide polymorphism in the FGFR explain the connection between diabetes and cancer?Emily J Gallagher, Derek LeRoith
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|June 27, 2023
Optimal Management of Insulin in Patients Undergoing 18F-Fluorodeoxyglucose Positron Emission Tomography ScansShivani Seth, Emily J Gallagher
Endocrinology|September 15, 2018
Diabetes, Obesity, and Breast CancerChifei Kang, Derek LeRoith, Emily J Gallagher
The Mount Sinai Journal of Medicine, New York|October 21, 2010
Insulin resistance in obesity as the underlying cause for the metabolic syndromeEmily J Gallagher, Derek Leroith, Eddy Karnieli
Journal for Immunotherapy of Cancer|September 13, 2019
Recovery from secondary adrenal insufficiency in a patient with immune checkpoint inhibitor therapy induced hypophysitisSahityasri Thapi, Amanda Leiter, Matthew Galsky, et al.
Pageof 8

Showing results (1-10 of 76) with videos related to

Sort By:
Pageof 8
Diabetes Care|July 25, 2013
Epidemiology and molecular mechanisms tying obesity, diabetes, and the metabolic syndrome with cancerEmily J Gallagher, Derek LeRoith
Cancer Metastasis Reviews|July 8, 2022
Obesity and cancerEmily J Gallagher, Derek LeRoith
Nature Reviews. Cancer|September 10, 2020
Hyperinsulinaemia in cancerEmily J Gallagher, Derek LeRoith
Current Opinion in Endocrinology, Diabetes, and Obesity|August 27, 2013
Diabetes, antihyperglycemic medications and cancer risk: smoke or fire?Emily J Gallagher, Derek LeRoith
Endocrinology|May 5, 2011
Minireview: IGF, Insulin, and CancerEmily J Gallagher, Derek LeRoith
Cell Metabolism|June 11, 2013
Does a single nucleotide polymorphism in the FGFR explain the connection between diabetes and cancer?Emily J Gallagher, Derek LeRoith
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|June 27, 2023
Optimal Management of Insulin in Patients Undergoing 18F-Fluorodeoxyglucose Positron Emission Tomography ScansShivani Seth, Emily J Gallagher
Endocrinology|September 15, 2018
Diabetes, Obesity, and Breast CancerChifei Kang, Derek LeRoith, Emily J Gallagher
The Mount Sinai Journal of Medicine, New York|October 21, 2010
Insulin resistance in obesity as the underlying cause for the metabolic syndromeEmily J Gallagher, Derek Leroith, Eddy Karnieli
Journal for Immunotherapy of Cancer|September 13, 2019
Recovery from secondary adrenal insufficiency in a patient with immune checkpoint inhibitor therapy induced hypophysitisSahityasri Thapi, Amanda Leiter, Matthew Galsky, et al.
Pageof 8